Literature DB >> 18470720

Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.

R Brunkhorst1, O K Eberhardt, M Haubitz, F M Brunkhorst.   

Abstract

OBJECTIVE: To investigate whether serum procalcitonin (PCT) levels could be useful to differentiate between systemic infection and the activity of the underlying disease in autoimmune disease.
METHODS: In 18 patients with systemic lupus erythematodes (SLE) and 35 patients with systemic antineutrophil cytoplasmic antibody-associated vasculitis (AAV) clinical disease activity was assessed by score systems. Infection was defined by clinical and microbiological means. PCT was determined in parallel with concentrations of neopterin, interleukin-6 (IL-6), and C-reactive protein (CRP) in 397 serum samples.
RESULTS: Only in 3 of the 324 samples taken from patients with autoimmune disease but without concomitant infection, serum PCT levels were above the normal range (>0.5 ng/ml), whereas neopterin, CRP and IL-6 were elevated in patients with active underlying disease. All systemic infections (N=16 in AAV-patients) were associated with markedly elevated PCT-levels (mean+/-SD:1.93+/-1.19 ng/ml).
CONCLUSION: PCT may serve as a useful marker for the detection of systemic bacterial infection in patients with autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470720     DOI: 10.1007/BF02900738

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

Review 1.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

2.  Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.

Authors:  O K Eberhard; M Haubitz; F M Brunkhorst; V Kliem; K M Koch; R Brunkhorst
Journal:  Arthritis Rheum       Date:  1997-07

3.  High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis.

Authors:  Y Gérard; D Hober; S Petitjean; M Assicot; C Bohuon; Y Mouton; P Wattré
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

4.  Elevated serum procalcitonin levels in patients with melioidosis.

Authors:  M D Smith; Y Suputtamongkol; W Chaowagul; M Assicot; C Bohuon; S Petitjean; N J White
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

5.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

6.  Plasma neopterin as an adjunct to C-reactive protein in assessment of infection.

Authors:  J Sheldon; P G Riches; N Soni; E Jurges; M Gore; G Dadian; J R Hobbs
Journal:  Clin Chem       Date:  1991-12       Impact factor: 8.327

7.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.

Authors:  M H Liang; S A Socher; M G Larson; P H Schur
Journal:  Arthritis Rheum       Date:  1989-09

8.  Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?

Authors:  O K Eberhard; I Langefeld; E R Kuse; F M Brunkhorst; V Kliem; H J Schlitt; R Pichlmayr; K M Koch; R Brunkhorst
Journal:  Clin Transplant       Date:  1998-06       Impact factor: 2.863

9.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.

Authors:  R A Luqmani; P A Bacon; R J Moots; B A Janssen; A Pall; P Emery; C Savage; D Adu
Journal:  QJM       Date:  1994-11
  9 in total
  14 in total

1.  Procalcitonin kinetics: a reliable tool for diagnosis and monitoring of the course of bacterial infection in critically ill patients with autoimmune diseases.

Authors:  Yan Shi; Xi Rui
Journal:  Intensive Care Med       Date:  2013-09-27       Impact factor: 17.440

Review 2.  [Systemic lupus erythematosus. A problem based approach].

Authors:  S Kleinert; M Feuchtenberger; H-P Tony
Journal:  Internist (Berl)       Date:  2010-08       Impact factor: 0.743

3.  Evaluation of serum procalcitonin levels for diagnosis of secondary bacterial infections in visceral leishmaniasis patients.

Authors:  Neda Pasyar; Abdolvahab Alborzi; Gholam R Pouladfar
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 4.  Biomarkers in ANCA-Associated Vasculitis: Potential Pitfalls and Future Prospects.

Authors:  Adam D Morris; Anthony W Rowbottom; Francis L Martin; Alexander Woywodt; Ajay P Dhaygude
Journal:  Kidney360       Date:  2021-01-19

5.  Predicting bacterial infection risk in patients with ANCA-associated vasculitis in southwest China: development of a new nomogram.

Authors:  Naidan Zhang; Jiaxiang Sun; Chaixia Ji; Xiao Bao; Chenliang Yuan
Journal:  Clin Rheumatol       Date:  2022-08-02       Impact factor: 3.650

6.  C-reactive protein and the acute phase reaction in geriatric patients.

Authors:  Thomas Bertsch; Jakob Triebel; Cornelius Bollheimer; Michael Christ; Cornel Sieber; Klaus Fassbender; Hans Jürgen Heppner
Journal:  Z Gerontol Geriatr       Date:  2015-09-03       Impact factor: 1.281

7.  [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Authors:  F Speth; N Wellinghausen; J-P Haas
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

8.  Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Li-Na Liu; Peng Wang; Shi-Yang Guan; Xiao-Mei Li; Bao-Zhu Li; Rui-Xue Leng; Hai-Feng Pan
Journal:  Rheumatol Int       Date:  2017-10-03       Impact factor: 2.631

9.  Serum Procalcitonin as a Useful Serologic Marker for Differential Diagnosis between Acute Gouty Attack and Bacterial Infection.

Authors:  Sang Tae Choi; Jung Soo Song
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

10.  Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.

Authors:  K Herrmann; S Schinke; E Csernok; F Moosig; J U Holle
Journal:  Open Rheumatol J       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.